Private Equity
Helix, a provider of DNA-powered products, has raised $200 million in Series B financing. DFJ Growth led the round with participation from other investors that included Illumina, Kleiner Perkins Caufield & Byers, Mayo Clinic, Sutter Hill Ventures and Warburg Pincus. In conjunction with the funding, Barry Schuler, a partner at DFJ Growth and former chairman and CEO of America Online, will join the Helix board of directors.
1 min read · 01 March 2018
Ontario Capital Growth Corp (OCGC), a venture capital agency of the Ontario government, said it plans to launch a venture capital fund focused on giving local life sciences companies the financing they need to scale up and reach global markets. OCGC has issued an expression of interest to identify fund managers to collaborate with other institutional investors, such as corporations, banks and pension funds. The Ontario government has pledged to commit up to $50 million to venture capital funds specializing in investments in life sciences sectors.
3 min read · 01 March 2018
3 min read · 01 March 2018
1 min read · 01 March 2018
SaskWorks Venture Fund, a retail venture capital fund active in Saskatchewan, has raised $40 million in its latest fund-raising year, reaching the fund's subscription limit under federal and provincial tax laws. Managed by Regina-based private equity firm PFM Capital, SaskWorks invests in small and medium-sized private companies in the province. Established in 2001, the fund has more than 29,000 shareholders and over $491 million in assets under management.
2 min read · 28 February 2018
1 min read · 28 February 2018
New York City-based Quentis Therapeutics, a biotech company that focuses on treating cancer patients, has raised $48 million in Series A funding. The investors included Versant Ventures, Polaris Partners, AbbVie Ventures, Taiho Pharmaceutical Co. Ltd, Yonghua Capital, Alexandria Venture Investments and New York Ventures, the investment arm of Empire State Development.
1 min read · 28 February 2018
San Francisco-based Collective Health, a healthcare platform, has raised $110 million in funding. The investors included New Enterprise Associates, Founders Fund, GV, Maverick Ventures, Sun Life Financial and Mubadala Ventures.
1 min read · 28 February 2018
7 min read · 28 February 2018
Sante Ventures is seeking to raise $200 million for its third fund, according to an SEC filing. The Austin, Texas-based venture firm invests in early-stage life sciences and healthcare companies.
1 min read · 28 February 2018
